地高辛相互作用。奎尼丁和维拉帕米对洋地黄苷类药物药代动力学及受体结合的影响。 - Suppr

Suppr

超能文献

Digoxin interactions. The influence of quinidine and verapamil on the pharmacokinetics and receptor binding of digitalis glycosides.

作者信息

Pedersen K E

出版信息

Acta Med Scand Suppl. 1985;697:1-40.

PMID:3863471

Abstract

摘要

相似文献

Digoxin interactions. The influence of quinidine and verapamil on the pharmacokinetics and receptor binding of digitalis glycosides.地高辛相互作用。奎尼丁和维拉帕米对洋地黄苷类药物药代动力学及受体结合的影响。

Acta Med Scand Suppl. 1985;697:1-40.

Interactions between quinidine and cardiac glycosides involving mutual binding sites in the guinea pig.奎尼丁与强心苷在豚鼠体内涉及相互结合位点的相互作用。

J Pharmacol Exp Ther. 1981 Jul;218(1):108-14.

[Clinical pharmacology of digitalis glycosides].[洋地黄苷类的临床药理学]

Nihon Rinsho. 1982;40(11):2367-75.

Amiodarone, verapamil, and quinidine do not affect equilibrium binding of digoxin.胺碘酮、维拉帕米和奎尼丁不影响地高辛的平衡结合。

J Cardiovasc Pharmacol. 1990 Oct;16(4):519-22. doi: 10.1097/00005344-199010000-00001.

Update on the influence of quinidine and other agents on digitalis glycosides.奎尼丁及其他药物对洋地黄苷影响的最新研究进展

Am Heart J. 1984 Jan;107(1):143-6. doi: 10.1016/0002-8703(84)90148-0.

[The Na,K pump, the cellular receptor for digitalis glycosides].[钠钾泵，洋地黄苷的细胞受体]

Ugeskr Laeger. 1985 Dec 9;147(50):4078-81.

Interactions between digitalis and antiarrhythmic drugs.洋地黄与抗心律失常药物之间的相互作用。

N C Med J. 1985 Jan;46(1):25-8.

Cardiac glycoside interactions at 'silent' and at active receptors. Putative biochemical backgrounds and possible clinical relevance.强心苷在“沉默”受体和活性受体处的相互作用。推测的生化背景及可能的临床意义。

Neth J Med. 1985;28(10):393-400.

Characteristics of the digoxin-quinidine and digoxin-verapamil interactions in the rat kidney.

Res Commun Chem Pathol Pharmacol. 1984 Jul;45(1):3-18.

Current problems of digitalis treatment.洋地黄治疗的当前问题。

Ther Hung. 1982;30(4):163-7.

引用本文的文献

Interspecies comparison of putative ligand binding sites of human, rat and mouse P-glycoprotein.人、大鼠和小鼠 P-糖蛋白假定配体结合位点的种间比较。

Eur J Pharm Sci. 2018 Sep 15;122:134-143. doi: 10.1016/j.ejps.2018.06.022. Epub 2018 Jun 22.

Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.外排比率无法评估P-糖蛋白介导的吸收性转运减弱：P-糖蛋白对跨Caco-2细胞单层吸收性和分泌性转运的不对称效应。

Pharm Res. 2003 Aug;20(8):1200-9. doi: 10.1023/a:1025049014674.

Role of P-glycoprotein in pharmacokinetics: clinical implications.P-糖蛋白在药代动力学中的作用：临床意义。

Clin Pharmacokinet. 2003;42(1):59-98. doi: 10.2165/00003088-200342010-00003.

Clinical pharmacokinetic significance of the renal tubular secretion of digoxin.地高辛肾小管分泌的临床药代动力学意义。

Clin Pharmacokinet. 1987 Nov;13(5):334-43. doi: 10.2165/00003088-198713050-00004.

Calcium channel antagonists. Part IV: Side effects and contraindications drug interactions and combinations.钙通道拮抗剂。第四部分：副作用、禁忌、药物相互作用及联合用药

Cardiovasc Drugs Ther. 1988 Jul;2(2):177-89. doi: 10.1007/BF00051233.

Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques and treatment recommendations.洋地黄。临床药代动力学、治疗监测技术及治疗建议的最新进展。

Clin Pharmacokinet. 1988 Sep;15(3):165-79. doi: 10.2165/00003088-198815030-00002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验